Advertisement

Alport syndrome: deducing the mode of inheritance from the presence of haematuria in family members

  • Judy Savige
Educational Review

Abstract

The diagnosis of Alport syndrome is suspected when an individual has haematuria or renal failure, together with a hearing loss; haematuria or renal failure, and a family history of Alport syndrome; or a pathognomonic Alport feature, such as lenticonus, fleck retinopathy, a lamellated glomerular basement membrane (GBM), or a GBM that lacks the collagen IV α3α4α5 network. The diagnosis of Alport syndrome is optimally confirmed by the demonstration of a mutation in the COL4A5 gene or two mutations in trans in the COL4A3 or COL4A4 genes. In practice, genetic testing for Alport syndrome is not widely available, and even with testing, causative mutations are not demonstrated in 5% of cases. Often, haematuria is only known in some family members, and the other characteristic features are not present or have not been sought. Where Alport syndrome remains likely, it is important to distinguish between X-linked inheritance, which occurs in 85% of families, and autosomal recessive inheritance, in the remaining 15%. This distinction is important because different modes of inheritance mean that different family members are at risk of being affected. Clinicians generally rely on the presence of haematuria to identify affected individuals in families with suspected Alport syndrome and on the information from three-generational family trees to assess the likely mode of inheritance. While often helpful, this strategy can also be misleading. The major sources of error are families with few members or where few members are tested; families comprising mainly women, where the typical Alport features are absent; families where the father is not available for testing for haematuria; and families with a coincidental renal disease. These difficulties emphasise the helpfulness of genetic testing in distinguishing between X-linked and autosomal recessively inherited forms of Alport syndrome.

Keywords

Alport syndrome Thin basement membrane nephropathy Glomerular basement membrane COL4A5 mutations Next-generation sequencing Genetic testing Pedigree analysis 

Notes

Compliance with ethical standards

Conflict of interest

The author delares that she has no conflict of interest.

References

  1. 1.
    Grunfeld JP, Joly D (1997) Hereditary kidney diseases in adults. Rev Prat 47:1566–1569PubMedGoogle Scholar
  2. 2.
    Gubler M, Levy M, Broyer M, Naizot C, Gonzales G, Perrin D, Habib R (1981) Alport’s syndrome. A report of 58 cases and a review of the literature. Am J Med 70:493–505CrossRefGoogle Scholar
  3. 3.
    Habib R, Gubler MC, Hinglais N, Noel LH, Droz D, Levy M, Mahieu P, Foidart JM, Perrin D, Bois E, Grunfeld JP (1982) Alport’s syndrome: experience at Hopital Necker. Kidney Int Suppl 11:S20–S28PubMedGoogle Scholar
  4. 4.
    Kashtan CE, Atkin CL, Gregory MC, Michael AF (1989) Identification of variant Alport phenotypes using an Alport-specific antibody probe. Kidney Int 36:669–674CrossRefGoogle Scholar
  5. 5.
    Feingold J, Bois E, Chompret A, Broyer M, Gubler MC, Grunfeld JP (1985) Genetic heterogeneity of Alport syndrome. Kidney Int 27:672–677CrossRefGoogle Scholar
  6. 6.
    Barker DF, Hostikka SL, Zhou J, Chow LT, Oliphant AR, Gerken SC, Gregory MC, Skolnick MH, Atkin CL, Tryggvason K (1990) Identification of mutations in the COL4A5 collagen gene in Alport syndrome. Science 248:1224–1227CrossRefGoogle Scholar
  7. 7.
    Mochizuki T, Lemmink HH, Mariyama M, Antignac C, Gubler MC, Pirson Y, Verellen-Dumoulin C, Chan B, Schroder CH, Smeets HJ, Reeders ST (1994) Identification of mutations in the alpha 3(IV) and alpha 4(IV) collagen genes in autosomal recessive Alport syndrome. Nat Genet 8:77–81CrossRefGoogle Scholar
  8. 8.
    Savige J, Rana K, Tonna S, Buzza M, Dagher H, Wang YY (2003) Thin basement membrane nephropathy. Kidney Int 64:1169–1178CrossRefGoogle Scholar
  9. 9.
    Fallerini C, Dosa L, Tita R, Del Prete D, Feriozzi S, Gai G, Clementi M, La Manna A, Miglietti N, Mancini R, Mandrile G, Ghiggeri GM, Piaggio G, Brancati F, Diano L, Frate E, Pinciaroli AR, Giani M, Castorina P, Bresin E, Giachino D, De Marchi M, Mari F, Bruttini M, Renieri A, Ariani F (2014) Unbiased next generation sequencing analysis confirms the existence of autosomal dominant Alport syndrome in a relevant fraction of cases. Clin Genet 86:252–257CrossRefGoogle Scholar
  10. 10.
    Savige J, Gregory M, Gross O, Kashtan C, Ding J, Flinter F (2013) Expert guidelines for the management of Alport syndrome and thin basement membrane nephropathy. J Am Soc Nephrol 24:364–375CrossRefGoogle Scholar
  11. 11.
    Savige J, Ariani F, Mari F, Bruttini M, Renieri A, Gross O, Deltas C, Flinter F, Ding J, Gale DP, Nagel M, Yau M, Shagam L, Torra R, Ars E, Hoefele J, Garosi G, Storey H (2018) Expert consensus guidelines for the genetic diagnosis of Alport syndrome. Pediatr Nephrol.  https://doi.org/10.1007/s00467-018-3985-4
  12. 12.
    Jais JP, Knebelmann B, Giatras I, De Marchi M, Rizzoni G, Renieri A, Weber M, Gross O, Netzer KO, Flinter F, Pirson Y, Verellen C, Wieslander J, Persson U, Tryggvason K, Martin P, Hertz JM, Schroder C, Sanak M, Krejcova S, Carvalho MF, Saus J, Antignac C, Smeets H, Gubler MC (2000) X-linked Alport syndrome: natural history in 195 families and genotype- phenotype correlations in males. J Am Soc Nephrol 11:649–657PubMedGoogle Scholar
  13. 13.
    Fu XJ, Morisada N, Hashimoto F, Taniguchi-Ikeda M, Hashimura Y, Ohtsubo H, Ninchoji T, Kaito H, Nozu K, Takahashi E, Nakanishi K, Kurahashi H, Iijima K (2014) A patient with autosomal recessive Alport syndrome due to segmental maternal isodisomy. Hum Genome Var 1:14006CrossRefGoogle Scholar
  14. 14.
    Savige J, Colville D, Rheault M, Gear S, Lennon R, Lagas S, Finlay M, Flinter F (2016) Alport syndrome in women and girls. Clin J Am Soc Nephrol 11:1713–1720CrossRefGoogle Scholar
  15. 15.
    Storey H, Savige J, Sivakumar V, Abbs S, Flinter FA (2013) COL4A3/COL4A4 mutations and features in individuals with autosomal recessive Alport syndrome. J Am Soc Nephrol 24:1945–1954CrossRefGoogle Scholar
  16. 16.
    Hertz JM, Thomassen M, Storey H, Flinter F (2015) Clinical utility gene card for: Alport syndrome—update 2014. Eur J Hum Genet 23.  https://doi.org/10.1038/ejhg.2014.254
  17. 17.
    Lanteri M, Wilson D, Savige J (1996) Clinical features in two patients with IgA glomerulonephritis and thin-basement-membrane disease. Nephrol Dial Transplant 11:791–793CrossRefGoogle Scholar
  18. 18.
    Frasca GM, Soverini L, Gharavi AG, Lifton RP, Canova C, Preda P, Vangelista A, Stefoni S (2004) Thin basement membrane disease in patients with familial IgA nephropathy. J Nephrol 17:778–785PubMedGoogle Scholar
  19. 19.
    Ahmed F, Kamae KK, Jones DJ, Deangelis MM, Hageman GS, Gregory MC, Bernstein PS (2013) Temporal macular thinning associated with X-linked Alport syndrome. JAMA Ophthalmol 131:777–782CrossRefGoogle Scholar
  20. 20.
    Chen Y, Colville D, Ierino F, Symons A, Savige J (2018) Temporal retinal thinning and the diagnosis of Alport syndrome and thin basement membrane nephropathy. Ophthalmic Genet 39:208–214CrossRefGoogle Scholar
  21. 21.
    Gast C, Pengelly RJ, Lyon M, Bunyan DJ, Seaby EG, Graham N, Venkat-Raman G, Ennis S (2016) Collagen (COL4A) mutations are the most frequent mutations underlying adult focal segmental glomerulosclerosis. Nephrol Dial Transplant 31:961–970CrossRefGoogle Scholar
  22. 22.
    Yin-Yin C, You-Ming P, Yu-Mei L (2014) Delayed diagnosis of Alport syndrome without hematuria. Iran J Kidney Dis 8:250–251PubMedGoogle Scholar
  23. 23.
    Yoshioka K, Hino S, Takemura T, Maki S, Wieslander J, Takekoshi Y, Makino H, Kagawa M, Sado Y, Kashtan CE (1994) Type IV collagen alpha 5 chain. Normal distribution and abnormalities in X-linked Alport syndrome revealed by monoclonal antibody. Am J Pathol 144:986–996PubMedPubMedCentralGoogle Scholar
  24. 24.
    Gubler MC, Knebelmann B, Beziau A, Broyer M, Pirson Y, Haddoum F, Kleppel MM, Antignac C (1995) Autosomal recessive Alport syndrome: immunohistochemical study of type IV collagen chain distribution. Kidney Int 47:1142–1147CrossRefGoogle Scholar
  25. 25.
    Hashimura Y, Nozu K, Kaito H, Nakanishi K, Fu XJ, Ohtsubo H, Hashimoto F, Oka M, Ninchoji T, Ishimori S, Morisada N, Matsunoshita N, Kamiyoshi N, Yoshikawa N, Iijima K (2014) Milder clinical aspects of X-linked Alport syndrome in men positive for the collagen IV alpha5 chain. Kidney Int 85:1208–1213CrossRefGoogle Scholar
  26. 26.
    Fallerini C, Baldassarri M, Trevisson E, Morbidoni V, La Manna A, Lazzarin R, Pasini A, Barbano G, Pinciaroli AR, Garosi G, Frullanti E, Pinto AM, Mencarelli MA, Mari F, Renieri A, Ariani F (2017) Alport syndrome: impact of digenic inheritance in patients management. Clin Genet 92:34–44CrossRefGoogle Scholar
  27. 27.
    Mencarelli MA, Heidet L, Storey H, van Geel M, Knebelmann B, Fallerini C, Miglietti N, Antonucci MF, Cetta F, Sayer JA, van den Wijngaard A, Yau S, Mari F, Bruttini M, Ariani F, Dahan K, Smeets B, Antignac C, Flinter F, Renieri A (2015) Evidence of digenic inheritance in Alport syndrome. J Med Genet 52:163–174CrossRefGoogle Scholar
  28. 28.
    Tonna S, Wang YY, Wilson D, Rigby L, Tabone T, Cotton R, Savige J (2008) The R229Q mutation in NPHS2 may predispose to proteinuria in thin-basement-membrane nephropathy. Pediatr Nephrol 23:2201–2207CrossRefGoogle Scholar

Copyright information

© IPNA 2018

Authors and Affiliations

  1. 1.Department of Medicine, Melbourne Health and Northern HealthThe University of MelbourneParkvilleAustralia

Personalised recommendations